Nang Kuang Pharmaceutical Co., Ltd.
Research Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) on Bullrun: market cap TWD 3.18B, P/E 15.6, dividend yield 5.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1752.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyTWD
- Market capTWD 3.18B
- P/E15.6
- Dividend yield5.1%
- Financial periodQ2 2026
- RevenueTWD 538.59M
- Net incomeTWD 52.37M
- Free cash flowTWD 47.81M
- Gross margin36.8%
Valuation Snapshot
latest market cap is TWD 3.18B; P/E is 15.6; dividend yield is 5.1%.
Peer valuation comparison
Latest P/E is 15.59x versus a Healthcare sector median of 21.8x (28.5% below).
Latest dividend yield is 5.12% versus a Healthcare sector median of 2.41% (112.4% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 3.18B | 15.6 | 5.1% | 1.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.6 TWD, yield 5.1%.
About Nang Kuang Pharmaceutical Co., Ltd.
Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nang Kuang Pharmaceutical Co., Ltd.'s market cap?
Nang Kuang Pharmaceutical Co., Ltd.'s market capitalization is TWD 3.18B.
What is Nang Kuang Pharmaceutical Co., Ltd.'s P/E ratio?
Nang Kuang Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 15.6.
Does Nang Kuang Pharmaceutical Co., Ltd. pay a dividend?
Nang Kuang Pharmaceutical Co., Ltd. has a dividend yield of 5.1%.
What does Nang Kuang Pharmaceutical Co., Ltd. do?
Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.